Can FDA Approval Bolster DexCom?

percentage points vs basis points

DexCom, Inc recently received FDA approval for their new G7 continuous glucose monitor The improved device–and the relationships it is helping them build-show great promise for the future. DexCom stock has been struggling, but this news may be a catalyst. DexCom, Inc. (NASDAQ:DXCM) is a continuous glucose monitoring (CGM) company. In early December, they received approval […]